Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-23

FDA Approved: PERPHENAZINE — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Perphenazine by Endo USA, Inc., updating the drug's approval status and/or labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PERPHENAZINE (Perphenazine)

Snippet

SUPPL AP for PERPHENAZINE (PERPHENAZINE)